Treatment for genetic pancreatic cancer
Researchers at Israel’s Sheba Medical Center have had positive results in trials of Lynparza (olaparib) for treating pancreatic cancer in carriers of BRCA mutations. An international trial of 154 patients showed improved response, time to progression and quality of life.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink